<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Minoxidil (topical): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Minoxidil (topical): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Minoxidil (topical): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12254" href="/d/html/12254.html" rel="external">see "Minoxidil (topical): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F8774870"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Gainextra Mens;</li>
<li>Hair Regrowth Treatment Men [OTC];</li>
<li>Minoxidil for Men [OTC];</li>
<li>Rogaine Mens Extra Strength [OTC];</li>
<li>Rogaine Mens [OTC];</li>
<li>Rogaine Womens [OTC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52912155"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Apo-Gain;</li>
<li>Hair Regrowth Formula;</li>
<li>Minox;</li>
<li>Rogaine</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F8774876"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Topical Skin Product</li></ul></div>
<div class="block doa drugH1Div" id="F8774956"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="b27ed5df-b743-4435-ad8d-969ac3d5c7dd">Alopecia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Alopecia:</b>
<b>Topical:</b>
<b>Note:</b> Continuous therapy for 4 months may be necessary for hair growth.</p>
<p style="text-indent:-2em;margin-left:2em;">Females:</p>
<p style="text-indent:-2em;margin-left:4em;">Foam, aerosol 5%: Apply <sup>1</sup>/<sub>2</sub> capful once daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Solution 2%: Apply 1 mL twice daily.</p>
<p style="text-indent:-2em;margin-left:2em;">Males:</p>
<p style="text-indent:-2em;margin-left:4em;">Foam, aerosol 5%: Apply <sup>1</sup>/<sub>2</sub> capful twice daily.</p>
<p style="text-indent:-2em;margin-left:4em;">Solution 2% or 5%: Apply 1 mL twice daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990409"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling</p></div>
<div class="block doha drugH1Div" id="F50987652"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling</p></div>
<div class="block doe drugH1Div" id="F56614026"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F8774928"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Local erythema (6%), pruritus (6%)</p></div>
<div class="block coi drugH1Div" id="F8774925"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">OTC labeling: When used for self-medication, do not use if your degree of hair loss is different than that shown on the product labeling; if you have no family history of hair loss; if your hair loss is sudden and/or patchy; if your hair loss is associated with childbirth; if you do not know the reason for your hair loss; in pediatric patients &lt;18 years; if your scalp is red, inflamed, infected, irritated, or painful; or you use other medicines on the scalp. Do not use products on females that are labeled for use on males.</p></div>
<div class="block war drugH1Div" id="F8774926"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Hair color changes: Changes in hair color and/or texture may occur.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Heart disease: Due to potential systemic absorption with subsequent fluid/electrolyte changes, a careful risk to benefit assessment should be performed in patients with heart disease before the use of topical minoxidil.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Flammable: Formulations are flammable; avoid fire,  flame, or smoking immediately following application. </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Appropriate use: For topical use only on the scalp; do not apply to other parts of the body. Avoid contact with eyes, mouth, nose, or other mucous membranes. Not intended for frontal baldness or receding hairline Continued use is necessary to increase and maintain hair regrowth.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">•  Self-medication (OTC use): When used for self-medication (OTC), discontinue use and contact your contact health care provider if chest pain, rapid heartbeat, faintness, or dizziness occurs; weight gain (sudden, unexplained) occurs; swelling of the hands or feet occurs; scalp irritation or redness occurs; unwanted facial hair growth occurs; if you do not see hair regrowth 4 to 6 months (product dependent).</p></div>
<div class="block foc drugH1Div" id="F8774960"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Foam, External:</p>
<p style="text-indent:-2em;margin-left:4em;">Gainextra Mens: 5% (60 g) [contains cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;">Rogaine Mens: 5% (60 g) [contains cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;">Rogaine Mens Extra Strength: 5% (60 mL) [contains cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;">Rogaine Womens: 5% (60 g) [contains cetyl alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;">Solution, External:</p>
<p style="text-indent:-2em;margin-left:4em;">Hair Regrowth Treatment Men: 5% (60 mL) [contains alcohol, usp, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;">Minoxidil for Men: 2% (60 mL); 5% (60 mL, 120 mL)</p>
<p style="text-indent:-2em;margin-left:4em;">Rogaine: 2% (60 mL) [contains alcohol, usp, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;">Rogaine Extra Strength for Men: 5% (60 mL) [contains alcohol, usp, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;">Generic: 2% (60 mL); 5% (60 mL)</p></div>
<div class="block geq drugH1Div" id="F8774872"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F8774962"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Foam</b> (Rogaine Mens Extra Strength External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (60 g): $27.37</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>The pricing data provide a representative AWP and/or AAWP price from a single manufacturer of the brand and/or generic product, respectively. The pricing data should be used for benchmarking purposes only, and as such should not be used to set or adjudicate any prices for reimbursement or purchasing functions. Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F27746173"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Topical:</b> For topical administration on the scalp only; do not use on other parts of the body. Apply directly to the hair- thinning areas of scalp; massage into scalp with fingers; wash hands after application. Refer to manufacturer’s labeling for additional administration instructions.</p>
<p style="text-indent:-2em;margin-left:4em;">Foam: May melt upon contact with warm fingers; rinse fingers in cold water and thoroughly dry prior to use</p></div>
<div class="block use drugH1Div" id="F8774915"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Alopecia: </b>Treatment of alopecia androgenetica of the scalp</p></div>
<div class="block cyt drugH1Div" id="F13299719"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F8774932"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F8774921"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Adverse events have been observed in some animal reproduction studies following oral administration.</p></div>
<div class="block brc drugH1Div" id="F9773197"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Minoxidil is excreted in breast milk following oral administration. </p></div>
<div class="block pha drugH1Div" id="F8774952"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Stimulation of hair growth is secondary to vasodilation, increased cutaneous blood flow, and stimulation of resting hair follicles.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F10961988"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Anagen</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Edapil m | Follirest | Mino | Tylcore</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Edapil m</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Edapil m</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Hair plus back | Regaine</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Alostil</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Tugain</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Rogaine</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Women's regaine</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Edapil m</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Women's Rogaine</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Alopexy | Bald X | Hairgaine for Men | Hairgaine for Women | Hairgrow | Minoxil | Minoxil Forte | Regaine for Men Extra Strength | Regaine Regular Strength</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Regaine</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Androvium</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Folux Foaming | Regaine | Regaine women | Revoco hair</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Minoxidil Regular Strength solution [prescribing information]. San Antonio, TX: H-E-B; March 2008.</div>
</li>
<li>
<div class="reference">
                  Rogaine Men's Extra Strength foam (minoxidil) [prescribing information]. Skillman, NJ: Johnson and Johnson; received January 2021.</div>
</li>
<li>
<div class="reference">
                  Rogaine Men's solution (minoxidil) [prescribing information]. Skillman, NJ: Johnson and Johnson; received January 2021.</div>
</li>
<li>
<div class="reference">
                  Rogaine Women's foam (minoxidil) [prescribing information]. Newbrunswick, NJ: Johnson and Johnson; received February 2020.</div>
</li>
<li>
<div class="reference">
                  Rogaine Women's solution (minoxidil) [prescribing information]. Newbrunswick, NJ: Johnson and Johnson; no date.</div>
</li></ol></div><div id="topicVersionRevision">Topic 9617 Version 144.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
